Global Drug Screening Market Report and Forecast 2024-2032

Global Drug Screening Market Outlook

The global drug screening market value was USD 7.97 billion in 2023, driven by the increasing prevalence of drug abuse across the globe. The market size is anticipated to grow at a CAGR of 13.8% during the forecast period of 2024-2032 to achieve a value of USD 25.50 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be a Significant Regional Market for Drug Screening

North America is anticipated to be the largest regional market for drug screening. The dominance of the North American market can be ascribed to factors such as rising illicit drug usage, government funding available to combat drug abuse, regulations supporting drug screening, the rising incidence of accidents caused by alcohol impairment, and the presence of key players in the region. Also, various initiatives are being implemented by the United States government to monitor the symptoms and determine whether a person is under drug abuse. For example, the Patients and Communities Act of 2018 was enacted by the government of the United States to combat drug usage. As a result, increased drug and alcohol addiction and strict rules to detect intoxication in the body are likely to aid the market growth in the region over the forecast period. The increasing cases of accidents caused by drunk driving is another major factor expected to contribute to revenue growth in countries such as the United States over the forecast period.

Urine Samples Segment to Hold the Largest Market Share

Based on the sample type, the urine samples segment revenue is expected to expand at a rapid rate in the drug screening market throughout the forecast period as drug presence can be easily detected and is painless compared to a blood sample. Urine is the most commonly utilised for testing drug abuse, and it is a simple sample to analyse. The benefits it offers, such as cost-effectiveness, the high detection accuracy of multiple drugs and instant results, are further driving the growth of the market. Urine drug testing is a critical aspect of monitoring patients on long-term opioid therapy and has also been recommended for patients on a long-term benzodiazepine or stimulant therapy. Also, it is one of the crucial tests to check opioid dependency. Thus, the rising prevalence of opioid overdose is expected to drive market growth over the forecast period.

Market Segmentations

Drug screening is a technique for detecting illegal and prescription drugs in blood, urine, and other bodily fluids. Potential medications are found and optimised using this process before a candidate drug is chosen for clinical trials. In high-throughput screening tests, huge libraries of compounds are screened for a specific biological activity.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on products and services, the market includes:

• Drug Screening Product
  • Analytical Instruments
  • Rapid Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
• Drug Screening Service

By sample type, the market is divided into:

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other

The end-users of the market are:

• Drug Testing Laboratories
• Workplaces
• Criminal Justice and Law Enforcement Agencies
• Hospitals
• Drug Treatment Centres
• Individual Users
• Pain Management Centres
• Schools and Colleges

The regional markets for the drug screening market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Consumption of Drug and Alcohol Augmenting the Market Growth

The growth in the global drug screening market can be attributed to the growing drug and alcohol consumption, increasing road accidents due to overdose of drugs while driving, rising regulatory approvals for drug screening products and services, illegal alcohol use by teens, and prescription drug misuse. The development of advanced screening devices and growing awareness regarding the benefits of alcohol or drug screening in the workplace creates new opportunities for key players in the market. For example, advanced drug-testing processes can be used in the workplace to identify illicit narcotics in sweat molecules and saliva using fingerprint tests and mouth swabs. The "lab-on-a-chip" technology can identify amphetamines, MDMA, cocaine, and opiates, among other drugs.

In addition, rising government measures to counter drug misuse, an increase in clinical studies, and the enforcement of strict laws and regulations demanding alcohol and drug testing in public safety services are likely to boost the drug screening market’s growth over the forecast period. Furthermore, the screening is easy to implement, thus offering flexible and effective workplace drug testing, which is also expected to fuel market growth.

Key Players in the Global Drug Screening Market

The report gives a detailed analysis of the following key players in the global drug screening market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Laboratory Corporation of America® Holdings.
• Quest Diagnostics
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Alfa Scientific Designs Inc.
• OraSure Technologies, Inc.
• F. Hoffmann-La Roche Ltd
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report